68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

NCT02174679 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

OTHER

Sponsor class

Conditions

Carcinoid Cancer
Neuroendocrine Tumors
Medullary Thyroid Cancer
Cancers Expressing Somatostatin Receptors

Interventions

DRUG: 68Ga DOTATATE

Sponsor

Jonsson Comprehensive Cancer Center